De Clercq E
Viruses. 2011; 2(6):1322-1339.
PMID: 21994682
PMC: 3185982.
DOI: 10.3390/v2061322.
Lantto J, Haahr Hansen M, Rasmussen S, Steinaa L, Poulsen T, Duggan J
J Virol. 2010; 85(4):1820-33.
PMID: 21147924
PMC: 3028881.
DOI: 10.1128/JVI.02127-10.
Billiau A, Schonne E, Eyckmans L, DE SOMER P
Infect Immun. 1970; 2(6):698-704.
PMID: 16557902
PMC: 416077.
DOI: 10.1128/iai.2.6.698-704.1970.
Shearer J, Siemann L, Gerkovich M, House R
Antimicrob Agents Chemother. 2005; 49(7):2634-41.
PMID: 15980330
PMC: 1168682.
DOI: 10.1128/AAC.49.7.2634-2641.2005.
Prichard M, Kern E
Curr Drug Targets Infect Disord. 2005; 5(1):17-28.
PMID: 15777195
PMC: 4264105.
DOI: 10.2174/1568005053174627.
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
Quenelle D, Collins D, Kern E
Antiviral Res. 2004; 63(1):33-40.
PMID: 15196818
PMC: 9528221.
DOI: 10.1016/j.antiviral.2004.02.003.
Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
Quenelle D, Collins D, Kern E
Antimicrob Agents Chemother. 2003; 47(10):3275-80.
PMID: 14506041
PMC: 201130.
DOI: 10.1128/AAC.47.10.3275-3280.2003.
A review of compounds exhibiting anti-orthopoxvirus activity in animal models.
Smee D, Sidwell R
Antiviral Res. 2003; 57(1-2):41-52.
PMID: 12615302
PMC: 9628990.
DOI: 10.1016/s0166-3542(02)00199-7.
Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
De Clercq E
Clin Microbiol Rev. 2001; 14(2):382-97.
PMID: 11292644
PMC: 88980.
DOI: 10.1128/CMR.14.2.382-397.2001.
Effect of interferon, polyacrylin acid, and polymethacrylic acid on tail lesions on mice infected with vaccinia virus.
De Clercq E, DE SOMER P
Appl Microbiol. 1968; 16(9):1314-9.
PMID: 5676405
PMC: 547647.
DOI: 10.1128/am.16.9.1314-1319.1968.
Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness.
Hirsch M, Nahmias A, Murphy F, Kramer J
J Exp Med. 1968; 128(1):121-32.
PMID: 5662010
PMC: 2138509.
DOI: 10.1084/jem.128.1.121.
BL-20803, a new, low-molecular-weight interferon inducer.
SIMINOFF P, Bernard A, HURSKY V, PRICE K
Antimicrob Agents Chemother. 1973; 3(6):742-3.
PMID: 4790625
PMC: 444491.
DOI: 10.1128/AAC.3.6.742.
Antiviral activity and induction of interferon-like substance by quinacrine and acranil.
GLAZ E, Szolgay E, Stoger I, TALAS M
Antimicrob Agents Chemother. 1973; 3(5):537-41.
PMID: 4790609
PMC: 444452.
DOI: 10.1128/AAC.3.5.537.
Protection of mice against vaccinia virus by bacterial infection and sustained stimulation with specific bacterial antigens.
Allen E, MUDD S
Infect Immun. 1973; 7(1):62-7.
PMID: 4632135
PMC: 422639.
DOI: 10.1128/iai.7.1.62-67.1973.
N,N-dioctadecyl-N',N'-bis(2-hydroxyethyl) propanediamine: antiviral activity and interferon stimulation in mice.
HOFFMAN W, Korst J, Niblack J, Cronin T
Antimicrob Agents Chemother. 1973; 3(4):498-502.
PMID: 4364178
PMC: 444441.
DOI: 10.1128/AAC.3.4.498.
Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid.
Billiau A, Desmyter J, DE SOMER P
J Virol. 1970; 5(3):321-8.
PMID: 4314554
PMC: 376009.
DOI: 10.1128/JVI.5.3.321-328.1970.
Polyacetal carboxylic acids: a new group of antiviral polyanions.
Claes P, Billiau A, De Clercq E, Desmyter J, Schonne E, VANDERHAEGHE H
J Virol. 1970; 5(3):313-20.
PMID: 4314553
PMC: 376008.
DOI: 10.1128/JVI.5.3.313-320.1970.
Quantitation of tail lesions in vaccinia-infected mice.
Joshi N, Jones M, McColl J
Appl Microbiol. 1969; 18(5):935.
PMID: 4313173
PMC: 378117.
DOI: 10.1128/am.18.5.935-935.1969.
Thy 1+ asialo GM1+ dendritic epidermal cells in skin defense mechanisms of vaccinia virus-infected mice.
Ikeda S, Tominaga T, Nishimura C
Arch Virol. 1991; 117(3-4):207-18.
PMID: 1826826
DOI: 10.1007/BF01310766.
Activities of 5,6-dihydro-5-azathymidine against herpes simplex virus infections in mice.
RENIS H, Eidson E
Antimicrob Agents Chemother. 1979; 15(2):213-9.
PMID: 426515
PMC: 352635.
DOI: 10.1128/AAC.15.2.213.
